,
your personalized virtual assistant to find clinical trials. Go head, 
Louis V. Puneky
University of Mississippi Cancer ClinicJackson, Mississippi - 39216 (601-984-5590) |
- CLINICAL TRIALS 7
- CONDITIONS19
- INTERVENTIONS24
- SINCE2007
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
July 2009 - June 2012
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
May 2010 - April 2011
Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced High-Risk Neuroendocrine Tumor
December 2007 - January 2012
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
December 2008 - April 2015
Capecitabine Gemcitabine and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
December 2008 - December 2010
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
June 2007 - January 2010
Oxaliplatin Capecitabine Cetuximab and Radiation Therapy Followed By Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
February 2009 - December 2011
Breast Neoplasms
Lung Neoplasms
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Neoplasms
Neoplasm Metastasis
Carcinoma
Carcinoma, Non-Small-Cell Lung
Bone Neoplasms
Bone Marrow Diseases
Rectal Neoplasms
Colorectal Neoplasms
Neuroendocrine Tumors
Cholangiocarcinoma
Gallbladder Neoplasms
Bile Duct Neoplasms
Osteonecrosis
Carcinoma, Neuroendocrine
Intensity-Modulated Radiation Therapy
Laboratory Biomarker Analysis
Assessment Of Therapy Complications
Paclitaxel
Carboplatin
Bevacizumab
Fluorouracil
Leucovorin Calcium
Neoadjuvant Therapy
Erlotinib Hydrochloride
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Adjuvant Therapy
Radiation Therapy
Capecitabine
3-Dimensional Conformal Radiation Therapy
Oxaliplatin
Sorafenib Tosylate
Cetuximab
Irinotecan Hydrochloride
Therapeutic Surgical Procedure
Recombinant Interferon Alfa-2b
Octreotide Acetate
